Zhejiang Huaye Plastics Machinery
301616
Alnera Aluminium
301613
Tibet Duo Rui Pharmaceutical
301075
4
ChengDu Sheng Nuo Biotec
688117
5
Guangzhou Sie Consulting
300687
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 97.38%119.43M | 4.52%28.05M | 29.22%28.39M | 422.45%32.37M | 456.09%30.62M | 198.44%60.51M | 355.16%26.84M | 332.25%21.97M | 38.34%6.2M | 14.30%5.51M |
Operating revenue | 97.38%119.43M | 4.52%28.05M | 29.22%28.39M | 422.45%32.37M | 456.09%30.62M | 198.44%60.51M | 355.16%26.84M | 332.25%21.97M | 38.34%6.2M | 14.30%5.51M |
Cost of revenue | 80.08%118.28M | -3.72%28.4M | 34.83%29.62M | 307.54%29.79M | 341.04%30.47M | 154.07%65.68M | 288.31%29.5M | 239.40%21.97M | 17.79%7.31M | 23.87%6.91M |
Gross profit | 122.22%1.15M | 86.80%-351K | -123,200.00%-1.23M | 330.94%2.58M | 111.21%157K | 7.21%-5.18M | -56.47%-2.66M | 100.07%1K | 35.47%-1.12M | -84.58%-1.4M |
Operating expense | -53.32%61.41M | -118.46%-8.46M | -88.25%7.41M | 131.18%27.83M | 225.23%34.63M | 190.22%131.55M | 231.86%45.84M | 548.60%63.02M | 6.29%12.04M | 1.67%10.65M |
Selling and administrative expenses | -66.25%37.37M | -147.89%-14.12M | -97.18%1.7M | 97.58%22.17M | 180.81%27.62M | 163.33%110.7M | 132.03%29.49M | 569.27%60.15M | 5.77%11.22M | 1.09%9.84M |
-Selling and marketing expense | -25.07%7.51M | -70.39%645K | -71.69%1.28M | 33.78%2.58M | 115.85%3.01M | 92.33%10.03M | 38.81%2.18M | 227.71%4.53M | 70.23%1.93M | 23.25%1.39M |
-General and administrative expense | -70.35%29.85M | -154.07%-14.77M | -99.25%415K | 110.80%19.6M | 191.54%24.61M | 173.38%100.67M | 145.15%27.32M | 631.33%55.62M | -1.93%9.3M | -1.83%8.44M |
Research and development costs | 15.30%24.04M | -65.35%5.66M | 98.47%5.71M | 593.38%5.66M | 763.18%7.01M | 533.93%20.85M | 1,384.47%16.34M | 294.11%2.88M | 13.97%816K | 9.29%812K |
Operating profit | 55.93%-60.26M | 116.72%8.11M | 86.29%-8.64M | -92.01%-25.26M | -186.11%-34.47M | -168.59%-136.72M | -212.64%-48.5M | -467.42%-63.02M | -0.76%-13.15M | -7.27%-12.05M |
Net non-operating interest income expense | -190.23%-8.62M | -120.49%-2.95M | -123.21%-2.09M | -264.00%-1.91M | -877.19%-1.67M | -398.15%-2.97M | -1,866.18%-1.34M | -23,275.00%-935K | -218.18%-525K | 52.50%-171K |
Non-operating interest expense | 190.23%8.62M | 120.49%2.95M | 123.21%2.09M | 264.00%1.91M | 877.19%1.67M | 398.15%2.97M | 1,866.18%1.34M | 23,275.00%935K | 218.18%525K | -52.50%171K |
Other net income (expense) | 94.47%-6.32M | 93.29%-4.09M | 89.35%-1.51M | 100.49%150K | 89.59%-870K | -400.00%-114.31M | -638.81%-60.89M | -41.81%-14.22M | -457.40%-30.84M | -984.96%-8.35M |
Gain on sale of security | 76.64%-11.73M | -1,120.65%-9.81M | 88.57%-1.25M | 99.49%-154K | 93.64%-515K | -81.26%-50.23M | 89.50%-804K | -12.08%-10.93M | -224.21%-30.4M | -774.30%-8.1M |
Special income (charges) | 108.94%5.4M | 108.99%5.4M | --0 | --0 | ---- | -1,114.47%-60.37M | ---60.05M | --63K | -109.83%-389K | ---- |
-Less:Impairment of capital assets | --0 | ---- | ---- | ---- | ---- | --60.05M | ---- | ---- | ---- | ---- |
-Less:Other special charges | -1,755.83%-5.4M | ---- | ---- | ---- | ---- | 105.48%326K | --0 | ---63K | 109.83%389K | ---- |
Other non- operating income (expenses) | 100.32%12K | 845.45%328K | 92.11%-265K | 733.33%304K | -37.60%-355K | -236.48%-3.71M | 92.45%-44K | -1,095.37%-3.36M | 57.89%-48K | -111.48%-258K |
Income before tax | 70.40%-75.2M | 100.97%1.07M | 84.35%-12.24M | 39.31%-27.02M | -79.90%-37.01M | -241.57%-254M | -364.81%-110.73M | -269.82%-78.18M | -137.40%-44.52M | -93.23%-20.57M |
Income tax | 91.31%-287K | -171.91%-192K | 99.61%-14K | -35K | -46K | -3.3M | 267K | -3.57M | 0 | 0 |
Net income | 70.12%-74.91M | 101.14%1.27M | 83.61%-12.23M | 39.39%-26.98M | -79.68%-36.97M | -237.13%-250.7M | -365.93%-110.99M | -252.93%-74.61M | -137.40%-44.52M | -93.23%-20.57M |
Net income continuous Operations | 70.12%-74.91M | 101.14%1.27M | 83.61%-12.23M | 39.39%-26.98M | -79.68%-36.97M | -237.13%-250.7M | -365.93%-110.99M | -252.93%-74.61M | -137.40%-44.52M | -93.23%-20.57M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 70.12%-74.91M | 101.14%1.27M | 83.61%-12.23M | 39.39%-26.98M | -79.68%-36.97M | -237.13%-250.7M | -365.93%-110.99M | -252.93%-74.61M | -137.40%-44.52M | -93.23%-20.57M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 70.12%-74.91M | 101.14%1.27M | 83.61%-12.23M | 39.39%-26.98M | -79.68%-36.97M | -237.13%-250.7M | -365.93%-110.99M | -252.93%-74.61M | -137.40%-44.52M | -93.23%-20.57M |
Basic earnings per share | 74.83%-5.8 | 105.88%0.6 | 90.16%-0.94 | 48.30%-2.31 | -14.61%-3.36 | -117.48%-23.0448 | -200.56%-10.2029 | -217.02%-9.55 | -67.21%-4.4684 | -93.23%-2.9316 |
Diluted earnings per share | 74.83%-5.8 | 105.88%0.6 | 90.16%-0.94 | 48.30%-2.31 | -14.61%-3.36 | -117.48%-23.0448 | -200.56%-10.2029 | -217.02%-9.55 | -67.21%-4.4684 | -93.23%-2.9316 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |